The Advantages of Levodopa-Carbidopa Intestinal Gel for Patients with Advanced Parkinson’s Disease: A Systematic Review

BACKGROUND: Levodopa-carbidopa intestinal gel (LCIG) is a new type of administration that results in steadier levodopa plasma concentrations in advanced Parkinson’s disease (PD) patients and effectively reduces poor mobility and dyskinesia. METHODS: Electronic databases were searched up to January 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xing-Ru, Jiang, Zhi-Yu, Zhang, Zeng-Rui, Chen, Hui-Jun, Wu, Ke, He, Jin-Cai, Xie, Cheng-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050037/
https://www.ncbi.nlm.nih.gov/pubmed/32161444
http://dx.doi.org/10.2147/DDDT.S229621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050037/
https://www.ncbi.nlm.nih.gov/pubmed/32161444
http://dx.doi.org/10.2147/DDDT.S229621

Ejemplares similares